Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
NYSE COMPOSITE INDX
Gold
Crude Oil
INTELLIPHARMACEU RG
(NQ:
IPCI
)
0.5395
USD
+0.0169 (+3.23%)
Official Closing Price
/ Updated:
8:00 PM EDT, Apr 20, 2018
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
126,784
Open
0.5300
Bid (Size)
0.5000 (2000)
Ask (Size)
0.5395 (1900)
Prev. Close
0.5226
Today's Range
0.5220 - 0.5500
52wk Range
0.5100 - 2.920
Shares Outstanding
43,537,849
Dividend Yield
N/A
Performance
YTD
-35.89%
-35.89%
1 Month
-13.00%
-13.00%
3 Month
-39.01%
-39.01%
6 Month
-44.95%
-44.95%
1 Year
-72.47%
-72.47%
Top News
More News
Intellipharmaceutics Announces First Quarter 2018 Results
April 16, 2018
from
ACCESSWIRE
Intellipharmaceutics Announces Closing of US$1.8 Million Financing
March 21, 2018
from
ACCESSWIRE
More News
Read More
Intellipharmaceutics Announces US$1.8 Million Registered Direct Offering
March 19, 2018
from
ACCESSWIRE
Intellipharmaceutics Announces Closing of US$3.5 Million Financing
March 16, 2018
from
ACCESSWIRE
Intellipharmaceutics Announces US$3.5 Million Registered Direct Offering
March 14, 2018
from
Filing Services Canada
Intellipharmaceutics Announces US$3.5 Million Registered Direct Offering
March 14, 2018
from
ACCESSWIRE
Intellipharmaceutics Announces Fiscal Year 2017 Results
February 16, 2018
from
ACCESSWIRE
Intellipharmaceutics Sets Earnings Release Date for Year End 2017 Results
February 13, 2018
from
ACCESSWIRE
Intellipharmaceutics Meets with FDA Regarding Oxycodone ER NDA Development Program
February 09, 2018
from
ACCESSWIRE
Intellipharmaceutics Provides Operational Update
January 24, 2018
from
GlobeNewswire News Releases
Intellipharmaceutics Announces Receipt of Nasdaq Notice
December 05, 2017
from
GlobeNewswire News Releases
Stock Market JSON API
provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Six Financial